Loading...
OTCM
INLB
Market cap70kUSD
Nov 03, Last price  
0.00USD
Name

Item 9 Labs Corp

Chart & Performance

D1W1MN
OTCM:INLB chart
P/E
P/S
0.00
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
33.02%
Revenues
22m
-0.82%
0892,187341,991179,494113,022324,026243,9261,375,2954,933,9608,121,73321,937,22721,756,997
Net income
-31m
L+92.56%
-23,112-4,087,714-3,325,069-17,082,226-4,740,684-3,125,536-266,571-642,282-10,631,157-12,299,657-16,191,961-31,179,053
CFO
-2m
L-62.36%
-14,922-966,175-353,544-738,598-740,849-339,72468,906-975,762-2,393,428-1,141,416-5,989,581-2,254,362

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.
IPO date
Nov 03, 2011
Employees
97
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2022‑092021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT